SMMT insider filings

Summit Therapeutics Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen SMMT transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner2——4
Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner2——4
Soni Manmeet Singh — COO and CFO, Director1——2
Anand Bhaskar — Chief Accounting Officer1——1

Recent insider filings — Summit Therapeutics Inc.

FiledFormInsiderReported transactionsSource
2026-11-204DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerOption exercise (M): 300,000 @ $1.06 · Option exercise (M): 300,000 (derivative) @ $0EDGAR
2026-11-204Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerOption exercise (M): 300,000 @ $1.06 · Option exercise (M): 300,000 (derivative) @ $0EDGAR
2026-11-164Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerOption exercise (M): 500,000 @ $1.06 · Option exercise (M): 500,000 (derivative) @ $0EDGAR
2026-11-164DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerOption exercise (M): 500,000 @ $1.06 · Option exercise (M): 500,000 (derivative) @ $0EDGAR
2026-11-164Soni Manmeet Singh — COO and CFO, DirectorOption exercise (M): 100,000 @ $1.37 · Option exercise (M): 100,000 (derivative) @ $0EDGAR
2026-10-144Anand Bhaskar — Chief Accounting OfficerGrant/award (A): 100,000 @ $0EDGAR
2026-06-124Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerPurchase (P): 3,810,000 @ $13.12EDGAR
2026-06-124DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerPurchase (P): 3,810,000 @ $13.12EDGAR
2026-06-044Soni Manmeet Singh — COO and CFO, DirectorPurchase (P): 25,000 @ $14.46 · Purchase (P): 25,000 @ $14.43EDGAR
2026-06-044Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerPurchase (P): 100,000 @ $14.60EDGAR
2026-06-044DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerPurchase (P): 100,000 @ $14.60EDGAR
2026-01-124Anand Bhaskar — Chief Accounting OfficerGrant/award (A): 30,000 (derivative)EDGAR
2026-01-064Xia Yu — DirectorGrant/award (A): 35,000 (derivative)EDGAR
2026-01-064Cesano Alessandra — DirectorGrant/award (A): 35,000 (derivative) · Grant/award (A): 3,219 (derivative) @ $8.76EDGAR
2026-01-064Clark Kenneth A — DirectorGrant/award (A): 35,000 (derivative) · Grant/award (A): 17,796 (derivative) @ $8.76EDGAR
2026-01-064Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 11,232 (derivative) @ $8.76EDGAR
2026-01-064Booth Robert F. — DirectorGrant/award (A): 35,000 (derivative) · Grant/award (A): 7,180 (derivative) @ $8.76EDGAR
2026-01-064Huber Jeff — DirectorGrant/award (A): 35,000 (derivative) · Grant/award (A): 9,885 (derivative) @ $8.76EDGAR
2026-01-064Ronaghi Mostafa — DirectorGrant/award (A): 35,000 (derivative)EDGAR
2026-01-064DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 11,232 (derivative) @ $8.76EDGAR
2025-10-234Xia Yu — DirectorPurchase (P): 533,617 @ $18.74EDGAR
2025-10-234Anand Bhaskar — Chief Accounting OfficerGrant/award (A): 26,680 @ $18.74EDGAR
2025-10-234Soni Manmeet Singh — COO and CFO, DirectorGrant/award (A): 53,361 @ $18.74EDGAR
2025-10-234Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 266,808 @ $18.74 · Purchase (P): 26,680 @ $18.74 · Grant/award (A): 13,980,789 @ $18.74EDGAR
2025-10-234DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 13,980,789 @ $18.74 · Grant/award (A): 266,808 @ $18.74 · Purchase (P): 26,680 @ $18.74EDGAR
2025-09-194Anand Bhaskar — Chief Accounting OfficerGrant/award (A): 50,000 (derivative)EDGAR
2025-09-114Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerPurchase (P): 333,394 @ $17.68 · Purchase (P): 5,000 @ $18.07EDGAR
2025-09-114DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerPurchase (P): 333,394 @ $17.68 · Purchase (P): 5,000 @ $18.07EDGAR
2025-06-024Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerOption exercise (M): 74,545 @ $2.64 · Option exercise (M): 74,545 (derivative) @ $0EDGAR
2025-06-024DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerOption exercise (M): 74,545 @ $2.64 · Option exercise (M): 74,545 (derivative) @ $0EDGAR
2025-05-014Anand Bhaskar — Chief Accounting OfficerGrant/award (A): 600,000 (derivative) · Grant/award (A): 75,000 (derivative)EDGAR
2025-05-014Soni Manmeet Singh — COO and CFO, DirectorGrant/award (A): 11,200,000 (derivative)EDGAR
2025-05-014Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 1,040,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 9,590,558 (derivative)EDGAR
2025-05-014DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 1,040,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 9,590,558 (derivative)EDGAR
2025-04-094Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerOption exercise/expiry (X): 3,985,055 @ $1.58 · Option exercise/expiry (X): 3,985,055 (derivative) @ $0EDGAR
2025-04-094DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerOption exercise/expiry (X): 3,985,055 @ $1.58 · Option exercise/expiry (X): 3,985,055 (derivative) @ $0EDGAR
2025-01-144Anand Bhaskar — Chief Accounting OfficerGrant/award (A): 75,000 (derivative)EDGAR
2025-01-064Xia Yu — DirectorGrant/award (A): 35,000 (derivative) · Grant/award (A): 5,438 (derivative) @ $9.18EDGAR
2025-01-064Cesano Alessandra — DirectorGrant/award (A): 35,000 (derivative) · Grant/award (A): 3,073 (derivative) @ $9.18EDGAR
2025-01-064Clark Kenneth A — DirectorGrant/award (A): 35,000 (derivative) · Grant/award (A): 16,991 (derivative) @ $9.18EDGAR
2025-01-064Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 10,724 (derivative) @ $9.18EDGAR
2025-01-064Huber Jeff — DirectorGrant/award (A): 35,000 (derivative)EDGAR
2025-01-064DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 10,724 (derivative) @ $9.18EDGAR
2024-10-154Clark Kenneth A — DirectorGrant/award (A): 200,000 (derivative)EDGAR
2024-10-034Zanganeh Mahkam — Co-Chief Executive Officer, DirectorOption exercise/expiry (X): 315,681 @ $1.58 · Option exercise/expiry (X): 315,681 (derivative) @ $0EDGAR
2024-09-134Anand Bhaskar — Chief Accounting OfficerGrant/award (A): 22,026 @ $22.70EDGAR
2024-09-134Soni Manmeet Singh — COO and CFO, DirectorGrant/award (A): 44,052 @ $22.70EDGAR
2024-09-134Zanganeh Mahkam — Co-Chief Executive Officer, DirectorGrant/award (A): 44,052 @ $22.70EDGAR
2024-09-134Huber Jeff — DirectorGrant/award (A): 44,052 @ $22.70EDGAR
2024-09-134DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% ownerGrant/award (A): 3,325,991 @ $22.70EDGAR

Recent 8-K events — Summit Therapeutics Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-188-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-168-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K2.02 — Results of Operations and Financial Condition
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-298-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-158-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-268-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=SMMT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs